These seven cell lines had significantly higher expression of CDX2 than the other 46 colorectal carcinoma (Wilcoxon rank-sum test P = 0.01), with four of seven also having chr 13q gain (the remaining three samples did not have CN status data). Here, CDX2 is linked to colorectal carcinoma.